UBP1

UBP1 (LBP-1a/NF2d9) is a TFCP2/Grainyhead-family transcription factor that functions as a context-dependent transcriptional activator or repressor. It binds DNA as a multimer and represses HIV-1 transcription by occluding the TATA element to block TFIID recruitment, and it directly occupies immunoglobulin switch regions to repress IgA class switch recombination in B lymphocytes (PMID:2006421, PMID:19384868). UBP1 lacks its own nuclear localization signal and requires heterodimerization with the related factor LBP-1b for nuclear import, after which it accumulates in PML body-associated speckles (PMID:16115195). Genetic ablation in mice causes embryonic lethality by E11.5 due to defective extraembryonic angiogenesis, and the UBP1 locus is a blood pressure determinant linked to transcriptional activation of the steroidogenic enzyme CYP11A (PMID:15282311, PMID:19662162).

1. 1991 High

   The first mechanistic question—how host factors repress HIV-1 transcription—was answered by showing that LBP-1 (including UBP1/LBP-1a) directly competes with TFIID at the HIV-1 TATA element, establishing UBP1 as a transcriptional repressor operating through steric exclusion of the basal machinery.

   Evidence In vitro transcription, DNase I footprinting, gel shift, and site-directed mutagenesis in stable cell lines

   PMID:2006421

   Open questions at the time

   • Identity and number of distinct LBP-1 polypeptides were unknown
   • Whether UBP1 could also activate transcription was not addressed
   • In vivo physiological relevance of HIV-1 repression was untested
2. 1994 High

   Molecular cloning resolved the LBP-1 family into four alternatively spliced isoforms from two genes and revealed that UBP1 binds DNA as a multimer, can activate transcription in a promoter-context-dependent manner, and is subject to dominant-negative regulation by a truncated isoform.

   Evidence cDNA cloning, recombinant protein DNA-binding assays, cell-free transcription, and in vivo reporter assays

   PMID:8114710

   Open questions at the time

   • How promoter context switches UBP1 from repressor to activator was undefined
   • No information on subcellular trafficking of individual isoforms
   • Physiological target genes beyond HIV-1 were unidentified
3. 2000 Medium

   Identification of UBP1-family regulation of CYP11A1 (P450scc) in placenta showed that LBP-1b activates while the related factor LBP-9 suppresses this activation, establishing antagonistic family-member control over steroidogenic gene expression.

   Evidence Yeast one-hybrid/two-hybrid screens, RT-PCR, transient transfection reporter assays, antibody supershift

   PMID:10644752

   Open questions at the time

   • Direct role of UBP1/LBP-1a itself (versus LBP-1b) at the CYP11A1 promoter was not resolved
   • In vivo steroidogenic consequences were not measured
   • Structural basis for antagonism between family members was unknown
4. 2004 High

   Two contemporaneous studies expanded UBP1's target gene repertoire (CYP2A8 activation via PREX element binding) and, critically, demonstrated that UBP1 knockout in mice causes embryonic lethality by E11.5 from defective extraembryonic angiogenesis, establishing an essential developmental function.

   Evidence EMSA and reporter assays for CYP2A8; conditional KO mice with histology, immunohistochemistry, and tetraploid complementation for angiogenesis phenotype

   PMID:15282311 PMID:15716014

   Open questions at the time

   • Downstream transcriptional targets mediating the angiogenic defect were not identified
   • Whether heterodimer composition determines tissue-specific functions was unexplored
   • No rescue experiment was performed to test sufficiency
5. 2005 Medium

   The long-standing question of how UBP1 reaches its nuclear targets was resolved: UBP1 is cytosolic when expressed alone and depends on heterodimerization with LBP-1b (which harbors an NLS) for nuclear import, after which it localizes to PML body-associated speckles.

   Evidence YFP-fusion imaging and co-expression experiments in COS-7 cells with NLS mapping

   PMID:16115195

   Open questions at the time

   • Functional significance of PML body colocalization was not determined
   • Whether endogenous LBP-1b availability limits UBP1 activity in vivo was untested
   • Post-translational modifications regulating the interaction were not explored
6. 2009 High

   UBP1's role was extended to adaptive immunity: ChIP demonstrated direct occupancy of immunoglobulin switch regions Sμ and Sα in B cells, and loss-of-function in hematopoietic lineages enhanced IgA (but not IgG1) class switch recombination, establishing UBP1 as an isotype-specific repressor of CSR. Concurrently, QTL mapping linked the UBP1 locus to blood pressure in mice and humans via CYP11A-dependent steroid/aldosterone biosynthesis.

   Evidence ChIP in primary splenic B cells, bone marrow chimeric mice with CSR analysis; QTL mapping in BXD strains and human SNP association

   PMID:19384868 PMID:19662162

   Open questions at the time

   • Mechanism by which UBP1 occupancy at switch regions blocks recombination was unclear
   • Causal variant at the human UBP1 locus affecting blood pressure was not pinpointed
   • Whether UBP1's angiogenic and steroidogenic roles converge in placental physiology was unexplored
7. 2025 Medium

   A new subcomplex of MED16 (dissociated from core Mediator) with UBP1 and TFCP2 was identified, resolving how UBP1 exerts dual transcriptional effects: the complex activates genes when its binding motif is proximal to the TSS but represses HIV-1 transcription when the motif overlaps the TSS by blocking preinitiation complex assembly.

   Evidence Protein purification/mass spectrometry, gene expression analysis, genomic motif analysis, HIV-1 transcription assay (preprint)

   PMID:bio_10.1101_2025.08.12.669905

   Open questions at the time

   • Preprint not yet peer-reviewed; awaits independent validation
   • Structural basis for motif-position-dependent switching between activation and repression is unresolved
   • Whether the MED16-UBP1-TFCP2 subcomplex operates in B cells or placental angiogenesis is untested

• Key unresolved questions include the identity of direct transcriptional targets mediating the embryonic angiogenic defect, the structural basis for the positional switch between activation and repression by the MED16-UBP1-TFCP2 complex, and the causal variants and tissue-specific mechanisms underlying the UBP1-blood pressure association in humans.
• No transcriptome-wide target identification in the embryonic extraembryonic vasculature
• No structural model for UBP1 or its complexes
• Mechanism by which switch-region occupancy blocks CSR remains undefined